Australia markets closed

Viridian Therapeutics, Inc. (VRDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.88+0.18 (+1.42%)
At close: 04:00PM EDT
12.88 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
102,827
155,579
42,299
45,897
Other short-term investments
374,543
268,971
154,666
81,742
Total cash
477,370
424,550
196,965
127,639
Other current assets
9,006
6,521
2,747
1,972
Total current assets
486,478
431,173
200,163
129,611
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,391
4,940
3,831
4,230
Accumulated depreciation
-1,049
-2,004
-1,776
-3,443
Net property, plant and equipment
3,342
2,936
2,055
787
Other long-term assets
604
982
1,491
1
Total non-current assets
3,946
3,918
3,546
1,644
Total assets
490,424
435,091
203,709
131,255
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
2,239
14,234
2,329
670
Accrued liabilities
12,652
13,342
6,746
7,185
Deferred revenues
288
288
289
301
Other current liabilities
100
100
100
100
Total current liabilities
26,635
33,349
13,636
10,674
Non-current liabilities
Long-term debt
20,205
4,645
-
-
Deferred revenues
573
861
1,149
-
Other long-term liabilities
989
1,172
1,208
43
Total non-current liabilities
21,767
6,678
2,357
544
Total liabilities
48,402
40,027
15,993
11,218
Stockholders' equity
Common stock
207,056
142,561
134,072
180,843
Retained earnings
-725,908
-488,174
-358,300
-278,887
Accumulated other comprehensive income
338
-390
-157
-8
Total stockholders' equity
442,022
395,064
187,716
120,037
Total liabilities and stockholders' equity
490,424
435,091
203,709
131,255